WallStreetZenWallStreetZen

NASDAQ: PRTC
Puretech Health PLC Stock

Overview
ForecastEarningsRevenueDividendOwnership
$16.74-0.01 (-0.06%)
Updated Apr 17, 2025
PRTC Price
$16.74
Fair Value Price
$0.32
Market Cap
$431.85M
52 Week Low
$13.30
52 Week High
$32.98
P/E
N/A
P/B
1.37x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.87
Operating Cash Flow
N/A
Beta
0.5
Next Earnings
Apr 23, 2025
Ex-Dividend
N/A
Next Dividend
N/A

PRTC Overview

PureTech Health plc is developing medicines for intractable cancers, as well as inflammatory, fibrotic and immunological, lymphatic and gastrointestinal, and neurological and neuropsychological diseases in the U.S. KarXT (to treat schizophrenia and psychosis in Alzheimer's disease) is currently in-market. Under development are a regenerative biology platform for androgenetic alopecia, epithelial ageing, and other medical conditions, an immunomodulation platform to treat chronic and acute inflammatory disorders, and oral therapies based on defined consortia of bacteria is isolated from the human microbiome. Puretech Health was incorporated in 2015 and is headquartered in Boston, MA.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine PRTC's potential to beat the market

View All “A” Zen Rated Stocks
→

Zen Rating Component Grades

N/A
Value
N/A
Growth
N/A
Momentum
N/A
Sentiment
N/A
Safety
N/A
Financials
N/A
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
PRTC
RankedUnranked of 463

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
Protalix Biotherapeutics (PLX)
$2.61A
Aurinia Pharmaceuticals (AUPH)
$7.75A
Rigel Pharmaceuticals (RIGL)
$16.85A
View Top Biotech Stocks

Be the first to know about important PRTC news, forecast changes, insider trades & much more!

PRTC News

Overview

Due Diligence Score

–
Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PRTC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PRTC ($16.74) is overvalued by 5,057.29% relative to our estimate of its Fair Value price of $0.32 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
PRTC ($16.74) is not significantly undervalued (5,057.29%) relative to our estimate of its Fair Value price of $0.32 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
PRTC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more PRTC due diligence checks available for Premium users.

Valuation

PRTC fair value

Fair Value of PRTC stock based on Discounted Cash Flow (DCF)

Price
$16.74
Fair Value
$0.32
Overvalued by
5,056.36%
PRTC ($16.74) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PRTC ($16.74) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation

PRTC price to earnings (PE)

For valuing profitable companies with steady earnings

Company
0x
Industry
-177.72x
Market
27.98x

PRTC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
1.37x
Industry
4.05x
PRTC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PRTC's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%

Assets to liabilities

Assets
$580.0M
Liabilities
$273.7M
Debt to equity
0.87
PRTC's short-term assets ($508.81M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PRTC's short-term assets ($508.81M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PRTC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A

PRTC vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
PRTC–$431.85M-0.04%N/A1.37x
MNMDD$434.88M+5.68%-3.75x1.80x
MGTXC$426.61M+1.69%-2.55x6.29x
TBPHC$426.44M+0.29%-7.50x2.43x
URGND$445.73M-6.93%-3.27x-50.63x
View Top Biotech Stocks

Puretech Health Stock FAQ

What is Puretech Health's quote symbol?

(NASDAQ: PRTC) Puretech Health trades on the NASDAQ under the ticker symbol PRTC. Puretech Health stock quotes can also be displayed as NASDAQ: PRTC.

If you're new to stock investing, here's how to buy Puretech Health stock.

What is the 52 week high and low for Puretech Health (NASDAQ: PRTC)?

(NASDAQ: PRTC) Puretech Health's 52-week high was $32.98, and its 52-week low was $13.30. It is currently -49.23% from its 52-week high and 25.89% from its 52-week low.

How much is Puretech Health stock worth today?

(NASDAQ: PRTC) Puretech Health currently has 257,927,489 outstanding shares. With Puretech Health stock trading at $16.74 per share, the total value of Puretech Health stock (market capitalization) is $431.85M.

Puretech Health stock was originally listed at a price of $40.19 in Nov 18, 2020. If you had invested in Puretech Health stock at $40.19, your return over the last 4 years would have been -58.34%, for an annualized return of -19.66% (not including any dividends or dividend reinvestments).

How much is Puretech Health's stock price per share?

(NASDAQ: PRTC) Puretech Health stock price per share is $16.74 today (as of Apr 17, 2025).

What is Puretech Health's Market Cap?

(NASDAQ: PRTC) Puretech Health's market cap is $431.85M, as of Apr 21, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Puretech Health's market cap is calculated by multiplying PRTC's current stock price of $16.74 by PRTC's total outstanding shares of 257,927,489.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.